AstraZeneca PLC (AZN.L)
AZN.L on London Stock Exchange
6,430.00GBp
9:04am BST
6,430.00GBp
9:04am BST
Change (% chg)
28.00 (+0.44%)
28.00 (+0.44%)
Prev Close
6,402.00
6,402.00
Open
6,420.00
6,420.00
Day's High
6,454.00
6,454.00
Day's Low
6,416.00
6,416.00
Volume
94,197
94,197
Avg. Vol
2,057,297
2,057,297
52-wk High
6,634.00
6,634.00
52-wk Low
5,312.00
5,312.00
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.98 | December | 19 Jul 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 7 | 7 | 7 | 7 |
| (2) OUTPERFORM | 10 | 10 | 10 | 10 |
| (3) HOLD | 6 | 6 | 6 | 6 |
| (4) UNDERPERFORM | 2 | 2 | 1 | 1 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.23 | 2.23 | 2.16 | 2.16 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 11 | 5,986.94 | 6,276.00 | 5,774.82 | 6,114.09 |
| Quarter Ending Dec-19 | 11 | 6,508.45 | 6,896.53 | 6,073.73 | 6,503.50 |
| Year Ending Dec-19 | 26 | 23,540.00 | 24,226.70 | 22,085.00 | 23,699.40 |
| Year Ending Dec-20 | 26 | 25,975.00 | 28,328.00 | 24,249.40 | 25,960.70 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 8 | 0.98 | 1.12 | 0.83 | 0.96 |
| Quarter Ending Dec-19 | 8 | 1.01 | 1.24 | 0.88 | 1.10 |
| Year Ending Dec-19 | 27 | 3.58 | 4.16 | 3.36 | 3.88 |
| Year Ending Dec-20 | 26 | 4.23 | 4.97 | 3.38 | 4.73 |
| LT Growth Rate (%) | 5 | 15.11 | 17.53 | 13.00 | 11.31 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-19 | 5,410.14 | 5,491.00 | 80.86 | 1.49 |
| Quarter Ending Dec-18 | 6,385.64 | 6,417.00 | 31.36 | 0.49 |
| Quarter Ending Sep-18 | 5,302.97 | 5,340.00 | 37.03 | 0.70 |
| Quarter Ending Jun-18 | 4,822.20 | 5,155.00 | 332.80 | 6.90 |
| Quarter Ending Mar-18 | 5,282.61 | 5,178.00 | 104.61 | 1.98 |
| Earnings (per share) | ||||
| Quarter Ending Mar-19 | 0.85 | 0.89 | 0.04 | 4.83 |
| Quarter Ending Dec-18 | 1.43 | 1.58 | 0.15 | 10.14 |
| Quarter Ending Sep-18 | 0.70 | 0.71 | 0.01 | 1.00 |
| Quarter Ending Jun-18 | 0.71 | 0.69 | 0.02 | 2.69 |
| Quarter Ending Mar-18 | 0.60 | 0.48 | 0.12 | 20.19 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 5,986.94 | 5,985.75 | 5,992.26 | 6,002.98 | 6,114.09 |
| Quarter Ending Dec-19 | 6,508.45 | 6,516.24 | 6,512.92 | 6,506.01 | 6,503.50 |
| Year Ending Dec-19 | 23,540.00 | 23,565.70 | 23,574.40 | 23,598.10 | 23,699.40 |
| Year Ending Dec-20 | 25,975.00 | 26,011.30 | 26,012.60 | 25,970.30 | 25,960.70 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 0.98 | 0.96 | 0.97 | 0.98 | 0.96 |
| Quarter Ending Dec-19 | 1.01 | 0.97 | 0.94 | 0.92 | 1.10 |
| Year Ending Dec-19 | 3.58 | 3.58 | 3.59 | 3.59 | 3.88 |
| Year Ending Dec-20 | 4.23 | 4.23 | 4.26 | 4.25 | 4.73 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-19 | 3 | 1 | 5 | 3 |
| Quarter Ending Dec-19 | 2 | 2 | 5 | 3 |
| Year Ending Dec-19 | 0 | 4 | 5 | 6 |
| Year Ending Dec-20 | 3 | 1 | 6 | 5 |
| Earnings | ||||
| Quarter Ending Sep-19 | 4 | 0 | 4 | 2 |
| Quarter Ending Dec-19 | 4 | 0 | 6 | 0 |
| Year Ending Dec-19 | 3 | 3 | 4 | 5 |
| Year Ending Dec-20 | 4 | 2 | 4 | 7 |
Earnings vs. 
Estimates- Exclusive: Woodford biotech stakes first off block in asset sale - source
- Exclusive: Woodford biotech stakes first off block in asset sale - source
- EXCLUSIVE-Woodford biotech stakes first off block in asset sale -source
- PRESS DIGEST- British Business - July 17
- FOCUS-As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff
- Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?
- What does AstraZeneca plc's deal with Pfizer mean for shareholders?
- 3 stocks to help you retire early
- Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
- These FTSE 100 stars have exploded in Q3! And they're not finished yet
- Why now is the perfect time to buy these 3 super income stocks